Tetragenex Pharmaceuticals, INC.
SEC CIK 1362659 · TTRX.OB · last insider filing 2007-11-30
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Cohen Aaron | Director | filed 2007 - 2007 |
| Schacker Martin F | Director · Co-CEO/ Chairman of the Board | filed 2007 - 2007 |
| Comer William T | Director | filed 2007 - 2007 |
| Cartwright Kenneth | Director · Senior Vice-President | filed 2007 - 2007 |
| Bergman Bruce J | Director | filed 2007 - 2007 |
| Akerman Alf E F | Director | filed 2007 - 2007 |
| Abel David | Director · Vice Chairman & Co-CEO | filed 2007 - 2007 |
| Budetti Robert Peter | Director · COO | filed 2007 - 2007 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Martucci Neil | Chief Financial Officer | filed 2007 - 2007 |
| Hamlin John W JR | Secretary/Treasurer | filed 2007 - 2007 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.